Literature DB >> 1855685

More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology.

D G Maxton1, J Morris, P J Whorwell.   

Abstract

The criteria now used in an attempt to distinguish irritable bowel syndrome from organic gastrointestinal disease rely almost entirely on symptoms of colonic origin. 'Non-colonic' symptoms, however, arising either from elsewhere in the gut or of a more general nature, are common in irritable bowel syndrome and may have even better diagnostic potential. The prevalence of these non-colonic features was assessed in 107 patients with the irritable bowel syndrome and 295 subjects with other gut disorders. Gastrointestinal type non-colonic symptoms are useful in differentiating irritable bowel syndrome from inflammatory bowel disease but, with the exception of early satiety, are not helpful when there is gastro-oesophageal or biliary disease. More general 'non-colonic' features, such as lethargy and backache, are much commoner in irritable bowel syndrome than in all the organic gastrointestinal diseases studied and have good discriminant function. Multiple logistic regression analysis identified certain features that had a particularly significant independent risk for irritable bowel syndrome. Those were lethargy (relative risk 6.7), incomplete evacuation (RR 5.2), age under 40 (RR 2.1), backache (RR 2.0), early satiety (RR 1.8), and frequency of micturition (RR 1.8). These relative risks can be multiplied together to give an overall risk when more than one of these features is present in a patient. Until a diagnostic test is available more confident diagnosis of irritable bowel syndrome can be achieved by identifying symptoms that have good discriminant function. The results of this study indicate that the non-colonic features of irritable bowel syndrome may be especially valuable in this respect.

Entities:  

Mesh:

Year:  1991        PMID: 1855685      PMCID: PMC1378996          DOI: 10.1136/gut.32.7.784

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Diagnostic value of the Manning criteria in irritable bowel syndrome.

Authors:  N J Talley; S F Phillips; L J Melton; C Mulvihill; C Wiltgen; A R Zinsmeister
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

2.  Ranking of symptoms by patients with the irritable bowel syndrome.

Authors:  D G Maxton; J A Morris; P J Whorwell
Journal:  BMJ       Date:  1989-11-04

3.  Oesophageal motility in the irritable bowel syndrome.

Authors:  P J Whorwell; C Clouter; C L Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

Review 4.  Psychological factors in the irritable bowel syndrome.

Authors:  F Creed; E Guthrie
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

5.  The irritable bowel syndrome: a paroxysmal motor disorder.

Authors:  D Kumar; D L Wingate
Journal:  Lancet       Date:  1985-11-02       Impact factor: 79.321

6.  Towards positive diagnosis of the irritable bowel.

Authors:  A P Manning; W G Thompson; K W Heaton; A F Morris
Journal:  Br Med J       Date:  1978-09-02

7.  A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease.

Authors:  W Kruis; C Thieme; M Weinzierl; P Schüssler; J Holl; W Paulus
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

8.  Non-colonic features of irritable bowel syndrome.

Authors:  P J Whorwell; M McCallum; F H Creed; C T Roberts
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

9.  Altered small bowel motility in irritable bowel syndrome is correlated with symptoms.

Authors:  J E Kellow; S F Phillips
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

10.  Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease.

Authors:  W G Thompson
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

View more
  26 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms.

Authors:  Joseph Zimmerman
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

Review 3.  Bringing science to the art of diagnosis.

Authors:  P Moayyedi
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

4.  Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?

Authors:  Magnus Simrén
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

5.  Non-colonic symptomatology and the irritable bowel: is it really of diagnostic value?

Authors:  C M Prather; A R Zinsmeister; N J Talley
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

Review 6.  Irritable bowel syndrome. Diagnosis in the managed care era.

Authors:  G F Longstreth
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

Review 7.  The irritable bowel syndrome.

Authors:  C Y Francis; P J Whorwell
Journal:  Postgrad Med J       Date:  1997-01       Impact factor: 2.401

8.  Effect of sleep quality on symptoms of irritable bowel syndrome.

Authors:  G Goldsmith; J S Levin
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

9.  Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule.

Authors:  Rok Seon Choung; G Richard Locke; Alan R Zinsmeister; Cathy D Schleck; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

Review 10.  Refractory inflammatory bowel disease-could it be an irritable bowel?

Authors:  Jie Meng; Anurag Agrawal; Peter J Whorwell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-11       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.